REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,189,811 | +0.0% | 70,516 | -10.8% | 0.00% | -33.3% |
| Q1 2023 | $7,186,590 | +266.4% | 79,043 | +53.1% | 0.00% | +200.0% |
| Q4 2022 | $1,961,234 | -15.5% | 51,625 | -32.4% | 0.00% | 0.0% |
| Q2 2022 | $2,320,000 | -57.7% | 76,351 | -54.4% | 0.00% | -50.0% |
| Q1 2022 | $5,482,000 | +141.1% | 167,329 | +94.1% | 0.00% | – |
| Q4 2021 | $2,274,000 | -81.2% | 86,222 | -28.3% | 0.00% | -100.0% |
| Q3 2021 | $12,093,000 | -8.7% | 120,183 | +28.5% | 0.00% | -20.0% |
| Q2 2021 | $13,241,000 | +21.2% | 93,561 | -14.6% | 0.01% | -16.7% |
| Q1 2021 | $10,925,000 | +42.6% | 109,574 | +76.8% | 0.01% | +50.0% |
| Q4 2020 | $7,661,000 | -43.2% | 61,974 | -55.2% | 0.00% | -50.0% |
| Q3 2020 | $13,491,000 | -3.3% | 138,489 | +54.8% | 0.01% | -20.0% |
| Q2 2020 | $13,955,000 | +15.0% | 89,446 | +6.4% | 0.01% | -16.7% |
| Q1 2020 | $12,131,000 | +847.0% | 84,054 | +1241.2% | 0.01% | +500.0% |
| Q4 2019 | $1,281,000 | +442.8% | 6,267 | +127.2% | 0.00% | – |
| Q1 2019 | $236,000 | – | 2,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |